CEO & Co-founder
Steve has 35 years’ experience building world-class teams, products and companies in precision medicine, drug discovery and computational biology in the UK, EU and USA.
He has developed world-leading AI enabled genomics, analytics, drug repurposing, precision medicine, and diagnostics tools for life science and healthcare including several patented inventions. He was Global Director of Research Informatics for Astra and involved in the early Human Genome project. Steve’s mission is to extend precision medicine into complex, chronic diseases with as yet unmet medical needs.
Steve is Chair of the UK BioIndustry Association’s Data, AI and Genomics Advisory Committee, Scientific Advisor to Our Future Health, Strategic Oversight Board member for UK Biobank and industry advisor to the Health Data Research Service. He is Expert in Residence at Oxford University, and former Co-Chair of the Complex Disorders Alliance’s SAB. He works with multiple disease charities, research institutes, and national policy initiatives on data, AI, and precision/preventive medicine strategy.
